Read closely / Read offers carefully
Which promises need a closer look?
Pause when an offer leaves the product, prescriber or pharmacy unclear. Ask for those details before weighing the price.
A prescription is a real requirement
Providing a prescription medicine without the required order from a licensed health professional broke federal law (September 26, 2026).
FDA listed the lack of a prescription requirement as an online-pharmacy warning sign.
Ask who evaluates you and who issues the prescription. A treatment menu leaves both questions open.
Check what approval statements mean
An NDC number means a National Drug Code, an identifying number used in a government drug list. A product having that number did not prove FDA approval (September 26, 2026).
FDA registration was no proof that a facility or its prepared medicines had approval.
FDA said a medicine made to order could not be presented as the same as an FDA-approved medicine, in guidance checked on September 26, 2026.
Federal law did not allow medicines made to order with retatrutide or cagrilintide, according to FDA on September 26, 2026.
Get the product's full name and ask if it is made to order. Ask what evidence supports what you have been told about it.
Treat price as part of the check
An online price that seems too low to be believable was one FDA warning sign (September 17, 2026).
A cheap cash offer alone did not prove anything was wrong. Real offers could be lower than the drug company's published price before discounts, called the list price.
Read the price alongside the prescription process and the pharmacy record. Get the written terms before agreeing to recurring charges.